MARKET

ORGS

ORGS

Orgenesis Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.200
+0.040
+0.96%
Closed 16:00 04/08 EDT
OPEN
4.250
PREV CLOSE
4.160
HIGH
4.840
LOW
3.780
VOLUME
114.26K
TURNOVER
--
52 WEEK HIGH
6.49
52 WEEK LOW
2.350
MARKET CAP
77.12M
P/E (TTM)
-2.7632
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ORGS stock price target is 9.00 with a high estimate of 9.00 and a low estimate of 9.00.

EPS

ORGS News

More
  • Orgenesis and ExcellaBio Announce Breakthrough Manufacturing Process for Bioxomes, Proprietary Synthetic Exosomes/Extracellular Vesicles (EV)
  • GlobeNewswire · 03/31 12:30
  • Orgenesis CEO Vered Caplan Provides Letter to Shareholders
  • GlobeNewswire · 03/30 12:30
  • Orgenesis reports FY results
  • seekingalpha · 03/10 16:41
  • Orgenesis Provides Fiscal 2019 Year-End Results and Business Update; Outlines New Vertically Integrated Business Model and POCare Strategy Following Sale of Masthercell
  • GlobeNewswire · 03/10 12:30

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About ORGS

Orgenesis Inc. is a biopharmaceutical company. The Company is developing, manufacturing and processing of technologies and services in the cell and gene therapy industry. The Company operates a point-of-care (POCare) cell therapy platform (POC). The POC platform develops Advanced Therapy Medicinal Products (ATMPs) through collaborations and in-licensing with other pre-clinical and clinical-stage biopharmaceutical companies and research and healthcare institutes to bring such ATMPs to patient. The POC platform include a multitude of cell therapies, including autoimmune, oncologic, neurologic and metabolic diseases and other indications.
More

Webull offers kinds of Orgenesis Inc stock information, including NASDAQ:ORGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGS stock news, and many more online research tools to help you make informed decisions.